Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Mittal

Showing results (121-130 of 195) with videos related to

Pageof 20
Sort By:
Cells|November 27, 2024
Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 DiabetesJordan Carroll, Jessie Chen, Rahul Mittal, et al.
Bioimpacts : BI|April 12, 2022
Recent advancements in cell-based models for auditory disordersJake Langlie, Ariel Finberg, Nathalie B Bencie, et al.
Anatomical Record (Hoboken, N.J. : 2007)|July 2, 2019
The Generation of Zebrafish Mariner Model Using the CRISPR/Cas9 SystemBing Zou, Alexandra A Desmidt, Rahul Mittal, et al.
Neuroscience and Biobehavioral Reviews|July 16, 2021
Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic reviewCamron Davies, Dibyanshi Mishra, Rebecca S Eshraghi, et al.
Neural Regeneration Research|March 9, 2022
Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid modelsJake Langlie, Rahul Mittal, Ariel Finberg, et al.
Journal of Clinical Medicine|July 15, 2026
Evolving Landscape of Regenerative Therapies: Cell-Based and Cell-Free Approaches for Chronic Low Back PainCourtney E Bartlett, Pareeshe Bansal, Siddhant Bhattacharya, et al.
Hearing Research|March 26, 2018
Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111)Adrien A Eshraghi, Mayank Aranke, Richard Salvi, et al.
Current Neuropharmacology|October 6, 2022
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological DisordersMatthew D Wiefels, Emily Furar, Rebecca S Eshraghi, et al.
Blood|December 18, 2012
Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse modelWanjing Ding, Hiroyuki Shimada, Lin Li, et al.
Artificial Cells, Nanomedicine, and Biotechnology|April 17, 2019
Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunitiesRahul Mittal, Stefanie A Pena, Angela Zhu, et al.
Pageof 20

Showing results (121-130 of 195) with videos related to

Sort By:
Pageof 20
Cells|November 27, 2024
Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 DiabetesJordan Carroll, Jessie Chen, Rahul Mittal, et al.
Bioimpacts : BI|April 12, 2022
Recent advancements in cell-based models for auditory disordersJake Langlie, Ariel Finberg, Nathalie B Bencie, et al.
Anatomical Record (Hoboken, N.J. : 2007)|July 2, 2019
The Generation of Zebrafish Mariner Model Using the CRISPR/Cas9 SystemBing Zou, Alexandra A Desmidt, Rahul Mittal, et al.
Neuroscience and Biobehavioral Reviews|July 16, 2021
Altering the gut microbiome to potentially modulate behavioral manifestations in autism spectrum disorders: A systematic reviewCamron Davies, Dibyanshi Mishra, Rebecca S Eshraghi, et al.
Neural Regeneration Research|March 9, 2022
Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid modelsJake Langlie, Rahul Mittal, Ariel Finberg, et al.
Journal of Clinical Medicine|July 15, 2026
Evolving Landscape of Regenerative Therapies: Cell-Based and Cell-Free Approaches for Chronic Low Back PainCourtney E Bartlett, Pareeshe Bansal, Siddhant Bhattacharya, et al.
Hearing Research|March 26, 2018
Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111)Adrien A Eshraghi, Mayank Aranke, Richard Salvi, et al.
Current Neuropharmacology|October 6, 2022
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological DisordersMatthew D Wiefels, Emily Furar, Rebecca S Eshraghi, et al.
Blood|December 18, 2012
Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse modelWanjing Ding, Hiroyuki Shimada, Lin Li, et al.
Artificial Cells, Nanomedicine, and Biotechnology|April 17, 2019
Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunitiesRahul Mittal, Stefanie A Pena, Angela Zhu, et al.
Pageof 20